Two new ligands, 2-[(bis(2-pyridylmethyl)amino)methyl]-4-methylphenol (HL) and 2-[(bis(2-pyridylmethyl)amino)methyl]-4-methyl-6-(methylthio)phenol (HSL), were synthesized and were used to prepare the trinuclear copper(II) complex {[CuSL(Cl)]2Cu}(PF6)2.H2O (1) and the corresponding binuclear complexes [Cu2(SL)2](PF6)2 (2) and [Cu2L2](PF6)2 (3). The crystal structure of 1 shows two different coordination environments: two square base pyramidal centers (Cu1 and Cu1a, related by a C2 axes), acting as ligands of a distorted square planar copper center (Cu2) by means of the sulfur atom of the SCH3 substituent and the bridging phenoxo oxygen atom of the ligand (Cu2-S = 2.294 A). Compounds 2 and 3 show two equivalent distorted square base pyramidal copper(II) centers, bridged in an axial-equatorial fashion by two phenoxo groups, thus defining an asymmetric Cu2O2 core. A long copper-sulfur distance measured in 2 (2.9261(18) A) suggests a weak bonding interaction. This interaction induces a torsion angle between the methylthio group and the phenoxo plane resulting in a dihedral angle of 41.4(5) degrees. A still larger distortion is observed in 1 with a dihedral angle of 74.0(6) degrees. DFT calculations for 1 gave a ferromagnetic exchange between first neighbors interaction, the calculated J value for this interaction being +11.7 cm-1. In addition, an antiferromagnetic exchange for 1 was obtained for the second neighbor interaction with a J value of -0.05 cm-1. The Bleaney-Bowers equation was used to fit the experimental magnetic susceptibility data for 2 and 3; the best fit was obtained with J values of +3.4 and -16.7 cm-1, respectively. DFT calculations for 2 and 3 confirm the nature and the values of the J constants obtained by the fit of the experimental data. ESR and magnetic studies on the reported compounds show a weak exchange interaction between the copper(II) centers. The low values obtained for the coupling constants can be explained in terms of a poor overlap between the magnetic orbitals, due to the axial-equatorial phenoxo bridging mode observed in these complexes.
Four mononuclear complexes [Cu(HL(1))Cl]PF(6).CH(3)OH (1), [Cu(HSL(1))Cl]PF(6).0.75H(2)O (2), [Cu(HL(2))Cl]PF(6).CH (3)OH (3), [Cu(HSL(2))Cl]PF(6).1.5CH(3)OH (4), and two polynuclear complexes [Cu (2)(SL(2))(2)](PF(6))(2).2CH(3)OH (5) and {Cu[Cu(SL(2))(Cl)](2)}(PF(6))(2) (6) (HL(1): 2-[(bis(2-pyridylmethyl)-amino)methyl]-4-methylphenol; HSL(1): 2-[(bis(2-pyridylmethyl)amino) methyl]-4-methyl-6-(methyl-thio)phenol; HL(2): 2-[(2-pyridylmethyl)(2'-pyridylethyl)-aminomethyl)]-4-methylphenol; HSL(2): 2-[(2-pyridylmethyl)(2'-pyridylethyl)amino-methyl]-4-methyl-6-(methylthio)phenol were obtained and characterized. The crystal structures of the mononuclear complexes 1-4 show the copper centers in a square-base pyramidal environment with the phenolic oxygen coordinated at the axial position. Dinuclear complex 5 has two copper centers with different geometry and bridged by phenoxo oxygens; one of the copper atoms is square pyramidal while the other can be described with a highly distorted octahedral geometry with a long Cu-S distance (2.867 A). Density functional theory calculations were used to obtain the reported structure of 6, since single crystals suitable for X-ray diffraction were not isolated. Magnetic studies done for 5 and 6 show an antiferromagnetic behavior for 5 (J = -134 cm(-1)) and a ferromagnetic behavior for 6 (J = +11.9 cm(-1)). Redox potentials for the mononuclear complexes were measured by cyclic voltammetry; the values show the effect of the chelating ring size (-213 mV and -142 mV for Cu-HL(1) and Cu-HL(2), respectively) and the presence of the thiomethyl substituent (-213 mV and -184 mV for Cu-HL(1) and Cu-HSL(1), respectively).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.